Treatment for Hives (Urticaria)
Second-generation H1 antihistamines are the first-line treatment for hives (urticaria), with doses that can be increased up to four times the standard dose for refractory cases. 1
Acute vs. Chronic Urticaria Management
Acute Urticaria Treatment
First-line therapy:
Second-generation (non-sedating) H1 antihistamines:
- Fexofenadine 180mg daily
- Cetirizine 10mg daily
- Loratadine 10mg daily 1
These are preferred due to minimal sedation and favorable safety profile
For severe or uncontrolled symptoms:
For refractory cases:
Chronic Urticaria Treatment (symptoms >6 weeks)
- Step 1: Second-generation H1 antihistamines at standard dose 1, 5
- Step 2: Increase dose up to 4× standard dose if inadequate response 1, 5
- Step 3: Add leukotriene receptor antagonists or consider referral for advanced therapies:
Important Clinical Considerations
Medication Selection Tips
- Avoid first-generation antihistamines in elderly patients due to increased fall risk and cognitive impairment 1
- Regular dosing is key - antihistamines should be used on a regular basis, not only after hives appear 4
- Corticosteroids should only be used for short periods (typically at doses equivalent to 40mg prednisone daily) with quick tapering to minimize side effects 4
Special Populations
- Children: Prefer second-generation antihistamines; avoid long-term oral corticosteroids 1
- Elderly: Avoid sedating antihistamines; use second-generation options 1
- Patients with diabetes/hypertension: Use corticosteroids with caution 1
When to Consider Anaphylaxis
If hives present with any of these symptoms, treat as anaphylaxis:
- Respiratory symptoms (shortness of breath, wheezing)
- Obstructive swelling of tongue/lips
- Circulatory symptoms (hypotension)
For anaphylaxis, immediate epinephrine administration is required, followed by H1+H2 antihistamine combination 1, 6
Monitoring and Follow-up
- Reassess within 1-2 weeks of initiating or changing therapy 1
- For chronic urticaria, periodically reassess the need for continued therapy 1
- Most patients with chronic urticaria will have resolution or improvement within a year 7
Common Pitfalls to Avoid
- Don't undertreat: Many patients require higher than standard antihistamine doses
- Don't rely on sedating antihistamines as first-line therapy due to side effects
- Don't use long-term corticosteroids for chronic urticaria management
- Don't forget to assess for underlying causes in chronic urticaria, though 80-90% are idiopathic 7
Remember that urticaria significantly impacts quality of life, with approximately 40% of chronic urticaria patients reporting a very large negative effect on quality of life 5. Prompt and effective treatment is essential for symptom control and improving patient wellbeing.